Joan Milostan v. Troy Internal Medicine

CourtMichigan Court of Appeals
DecidedJanuary 15, 2015
Docket317704
StatusUnpublished

This text of Joan Milostan v. Troy Internal Medicine (Joan Milostan v. Troy Internal Medicine) is published on Counsel Stack Legal Research, covering Michigan Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Joan Milostan v. Troy Internal Medicine, (Mich. Ct. App. 2015).

Opinion

STATE OF MICHIGAN

COURT OF APPEALS

JOAN MILOSTAN, UNPUBLISHED January 15, 2015 Plaintiff-Appellant,

v No. 317704 Oakland Circuit Court TROY INTERNAL MEDICINE, MARK ALLEN LC No. 2012-126758-NH SINKOFF, M.D., MICHAEL JOHN SIMPSON, M.D., NEIL FRASER, M.D.,

Defendants-Appellees.

Before: FORT HOOD, P.J., AND HOEKSTRA AND O’CONNELL, JJ.

PER CURIAM.

In this medical malpractice case, plaintiff challenges the trial court’s grant of summary disposition to defendant Dr. Neil Fraser, M.D., under MCR 2.116(C)(7) based on the expiration of the statute of limitations provided by MCL 600.5805(6). Because the applicable statute of limitations had expired, and the discovery rule contained in MCL 600.5828a(2) does not apply to plaintiff’s discovery of Dr. Fraser’s identity, we affirm the trial court’s grant of summary disposition.

The basic facts in this case are largely undisputed. Defendants Dr. Mark Sinkoff, Dr. Michael Simpson, and Dr. Fraser are partners in Troy Internal Medicine. In 2009, plaintiff was 77 years old and a long time patient of Troy Internal Medicine, in particular, a patient of Dr. Sinkoff. At that time, among other medications, plaintiff took Coumadin, an anticoagulant. Toward the end of 2009, plaintiff successfully underwent microsurgical clipping of a brain aneurysm, following which she was discharged from the hospital on December 22, 2009 and she resumed taking Coumadin. According to the affidavit of merit supporting plaintiff’s complaint, given plaintiff’s medical history, following her surgery, the standard of care required checking of plaintiff’s Coumadin levels every two to three days to ensure the proper therapeutic dosage.

After discharge from the hospital, plaintiff returned home where she received continuing care from home nurses. Her nurses reported to Troy Internal Medicine in regard to plaintiff’s Coumadin levels. Specifically, on December 26, 2009, plaintiff’s Coumadin levels were checked and reported to Dr. Simpson. Dr. Simpson ordered continuation of Coumadin and a re- check of plaintiff’s Coumadin levels on December 30, 2009. Per these instructions, plaintiff’s Coumadin levels were again checked on December 30, 2009, at which time those levels had

-1- risen significantly from December 26, 2009. Home care nurses, who were concerned by the levels, communicated those results to Troy Internal Medicine via telephone. Despite plaintiff’s significant rise in Coumadin levels, Dr. Fraser ordered continuation of the same dosage of Coumadin and a re-check of plaintiff’s Coumadin levels more than two weeks later.

Before this re-check occurred, in early January of 2010, plaintiff began experiencing new medical problems, including unsteady gait and balance, lethargy, headaches, facial pain, and double vision. Plaintiff’s daughter took her to the hospital on January 12, 2010, where testing revealed that plaintiff had a subdural hematoma due to excessively high Coumadin levels. Plaintiff’s condition necessitated a left frontal craniotomy “for evacuation of the brain bleeds.” As a result of bleeding on the brain, plaintiff suffered neurological damages, including speech, motor skill, and cognitive difficulties. It is plaintiff’s basic contention that those involved with her treatment breached the standard of care by failing to address whether the dosage was appropriate given the high levels of Coumadin in her blood and by ordering a recheck in two weeks, rather than more frequent checks.

On November 9, 2011, plaintiff sent a notice of intent to Dr. Sinkoff, Dr. Simpson, and Troy Internal Medicine. Her notice of intent also included reference to a “JohnDoe/Jane Doe, M.D,” an internist whose name was then unknown to plaintiff. In her notice of intent she detailed her injuries and she alleged among the negligent acts causing those injuries the decision made on December 30, 2009 to continue the same dosage of Coumadin and not to recheck her Coumadin levels for at least two weeks. She attributed this wrongful conduct to “Dr. Sinkoff, Dr. Simpson, Troy Internal Medicine, and others employed by Troy Internal Medicine.” On May 8, 2012, plaintiff filed her original complaint in the present suit. In her complaint, she named Dr. Simpson, Dr. Sinkoff, and Troy Internal Medicine.

However, neither plaintiff’s notice of intent nor her original complaint included Dr. Fraser because, according to plaintiff, she did not learn of his specific involvement in her treatment until September of 2012. In particular, on September 19, 2012, in response to interrogatories, Dr. Fraser’s name was given to plaintiff as a physician who was involved with her treatment. Proof of his involvement was evidenced by a “phone slip,” purportedly written by Dr. Fraser on December 31, 2009, although it does not appear to contain his signature or any other identifying information. After learning of Dr. Fraser’s involvement, plaintiff sent a second notice of intent on November 1, 2012, naming both Dr. Fraser and Troy Internal Medicine. Then, on January 8, 2013, plaintiff moved to amend her complaint to add Dr. Fraser as a defendant. Over objection from defendants, the trial court granted plaintiff’s motion and she amended her complaint to include Dr. Fraser as a defendant on February 4, 2013.

Dr. Fraser then moved for summary disposition pursuant to MCR 2.116(C)(7). He contended that plaintiff’s complaint was time barred by MCL 600.5805(6). In response, plaintiff argued that the discovery rule contained in MCL 600.5828a(2) applied, such that she had six months from the time she learned of Dr. Fraser’s involvement in which to file her suit. The trial court granted Dr. Fraser’s motion for summary disposition. Thereafter, an order entered dismissing plaintiff’s claims against the remaining defendants. Plaintiff now appeals as of right, challenging solely the trial court’s grant of summary disposition to Dr. Fraser.

-2- On appeal, this Court reviews de novo a trial court’s decision on a motion for summary disposition. DiPonio Const Co, Inc v Rosati Masonry Co, Inc, 246 Mich App 43, 46; 631 NW2d 59 (2001). Summary disposition is properly granted under MCR 2.116(C)(7) when a plaintiff’s complaint is barred by the applicable statute of limitations. Burton v Macha, 303 Mich App 750, 754; 846 NW2d 419 (2014). “When reviewing a motion for summary disposition under MCR 2.116(C)(7), the trial court must accept the nonmoving party’s well-pleaded allegations as true and construe the allegations in the nonmovant’s favor to determine whether any factual development could provide a basis for recovery.” Hoffman v Boonsiri, 290 Mich App 34, 39; 801 NW2d 385 (2010). When the facts are not in dispute, whether a cause of action is time barred by the applicable statute of limitations poses a question of law which this Court reviews de novo.1 Trentadue v Buckler Lawn Sprinkler, 479 Mich 378, 386; 738 NW2d 664 (2007).

As noted, the trial court granted summary disposition to Dr. Fraser because it determined plaintiff’s claims against him were time-barred by the applicable statute of limitations. Plaintiff contests this determination on appeal. She argues specifically that the discovery rule provided for in MCL 600.5838a(2) applies in this case and that, pursuant to this rule, she had six months from the discovery of Dr. Fraser’s identity to file suit, meaning that, according to plaintiff, her notice of intent to Dr. Fraser and the amendment of her complaint to include Dr. Fraser were timely.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Trentadue v. Buckler Automatic Lawn Sprinkler Company
479 Mich. 378 (Michigan Supreme Court, 2007)
Miller v. Mercy Memorial Hospital
644 N.W.2d 730 (Michigan Supreme Court, 2002)
Dessart v. Burak
652 N.W.2d 669 (Michigan Court of Appeals, 2002)
Poffenbarger v. Kaplan
568 N.W.2d 131 (Michigan Court of Appeals, 1997)
Rheaume v. Vandenberg
591 N.W.2d 331 (Michigan Court of Appeals, 1999)
Fazzalare v. Desa Industries, Inc
351 N.W.2d 886 (Michigan Court of Appeals, 1984)
Lefever v. American Red Cross
310 N.W.2d 278 (Michigan Court of Appeals, 1981)
Smith v. Sinai Hospital
394 N.W.2d 82 (Michigan Court of Appeals, 1986)
Hall v. Fortino
405 N.W.2d 106 (Michigan Court of Appeals, 1986)
Weisburg v. Lee
411 N.W.2d 728 (Michigan Court of Appeals, 1987)
Moll v. Abbott Laboratories
506 N.W.2d 816 (Michigan Supreme Court, 1993)
Walerych v. Isaac
234 N.W.2d 573 (Michigan Court of Appeals, 1975)
Solowy v. Oakwood Hospital Corp.
561 N.W.2d 843 (Michigan Supreme Court, 1997)
DiPonio Construction Co. v. Rosati Masonry Co.
631 N.W.2d 59 (Michigan Court of Appeals, 2001)
Peltier v. Eldredge
345 N.W.2d 605 (Michigan Court of Appeals, 1983)
Hoffman v. Boonsiri
801 N.W.2d 385 (Michigan Court of Appeals, 2010)
In re Stillwell Trust
829 N.W.2d 353 (Michigan Court of Appeals, 2012)
Burton v. Macha
846 N.W.2d 419 (Michigan Court of Appeals, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Joan Milostan v. Troy Internal Medicine, Counsel Stack Legal Research, https://law.counselstack.com/opinion/joan-milostan-v-troy-internal-medicine-michctapp-2015.